InsidersTradesSigma
SYN2BIO S.A.: directors' dealings · Poland · KNF
KNF:syn2bio-saPL·KNFMcap 288M€Healthcare
Explore the full insider trade history of SYN2BIO S.A., a listed issuer based in Poland. Shares are listed on PL PL, under the oversight of KNF. Operating in the Healthcare sector, SYN2BIO S.A. has published 4 insider filings. Market capitalisation: €288.1m. The latest transaction was reported on 18 May 2026 — Notification PDMR. Among the most active insiders: Anonymous (PDMR). Every trade is free.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended September 2025 · cache
33.00 €
Analyst consensus
1 analysts31.00 €Target 31.00 €(-6%)31.00 €
Income statement
Net income−23.7 M€0.0% margin
Balance sheet & cash
Market cap288.1 M€
Total debt651 k€
Free Cash Flow−21.1 M€
Profitability & ownership
% insiders0.0%
% institutions7.5%
Last declaration on 18 May 2026
Declarations4 total
Executives●Notification PDMR0KNF
KNF:node/718643·details not loaded
Executives●Notification PDMR0KNF
KNF:node/719461·details not loaded
Executives●Notification PDMR0KNF
KNF:node/719459·details not loaded
Executives●Notification PDMR0KNF
KNF:node/718695·details not loaded
4 of 4 declarations